Guidant and Medtronic get implantable cardioverter defibrillator (ICD) approvals
This article was originally published in Clinica
The US FDA has approved ICDs manufactured by Medtronic and Guidant for pectoral implantation. Guidant has received marketing approval for its 68 cc Ventak Mini Hot Can and 59 cc Mini II ICDs. Both devices use the Endotak Triad three-electrode lead system. The Mini Hot Can is 29% smaller than Medtronic's 83 cc Jewel - which was the first ICD to receive pectoral approval in the US in March 1995 (see Clinica No 647, p 19).
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.